Cargando…
Characteristics of in Vivo Model Systems for Ovarian Cancer Studies
An understanding of the molecular pathogenesis and heterogeneity of ovarian cancer holds promise for the development of early detection strategies and novel, efficient therapies. In this review, we discuss the advantages and limitations of animal models available for basic and preclinical studies. T...
Autores principales: | Tudrej, Patrycja, Kujawa, Katarzyna Aleksandra, Cortez, Alexander Jorge, Lisowska, Katarzyna Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787695/ https://www.ncbi.nlm.nih.gov/pubmed/31540126 http://dx.doi.org/10.3390/diagnostics9030120 |
Ejemplares similares
-
Advances in ovarian cancer therapy
por: Cortez, Alexander J., et al.
Publicado: (2017) -
Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
por: Kujawa, Katarzyna Aleksandra, et al.
Publicado: (2020) -
Evaluation of the Role of ITGBL1 in Ovarian Cancer
por: Cortez, Alexander Jorge, et al.
Publicado: (2020) -
Microfibril Associated Protein 5 (MFAP5) Is Related to Survival of Ovarian Cancer Patients but Not Useful as a Prognostic Biomarker
por: Kujawa, Katarzyna Aleksandra, et al.
Publicado: (2022) -
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival
por: Lisowska, Katarzyna M., et al.
Publicado: (2016)